CERo Therapeutics Holdings's total assets for Q4 2025 were $3.64M, a decrease of -6.91% from the previous quarter. CERO total liabilities were $9.09M for the fiscal quarter, a 7.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.